| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE | 29 |
| 1 | METHOTREXATE SODIUM | 29 |
| 2 | CYTARABINE | 20 |
| 3 | CYCLOPHOSPHAMIDE | 15 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 15 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 15 |
| 6 | BACLOFEN | 13 |
| 7 | DEXAMETHASONE | 13 |
| 8 | DEXAMETHASONE 1.5 MG | 13 |
| 9 | FUROSEMIDE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIDOCAINE, EPINEPHRINE | 1 | 0.1250 |
| 1 | ATRACURIUM BESYLATE | 10 | 0.0141 |
| 2 | BENZYL ALCOHOL | 1 | 0.0095 |
| 3 | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | 1 | 0.0084 |
| 4 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 3 | 0.0076 |
| 5 | PRAZIQUANTEL | 1 | 0.0033 |
| 6 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 7 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 8 | AMOXAPINE | 1 | 0.0021 |
| 9 | POTASSIUM IODIDE | 2 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 33 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 29 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 21 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 4 | Alkylating Drug [EPC] | 16 |
| 5 | Benzodiazepine [EPC] | 14 |
| 6 | Amide Local Anesthetic [EPC] | 13 |
| 7 | Insulin Analog [EPC] | 13 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 13 |
| 9 | Loop Diuretic [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Thyroid Hormone Synthesis Inhibitor [EPC] | 4 | 0.0004 |
| 4 | Anthelmintic [EPC] | 1 | 0.0003 |
| 5 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | General Anesthetic [EPC] | 11 | 0.0003 |
| 7 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 8 | Pediculicide [EPC] | 1 | 0.0002 |
| 9 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |